Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma
RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to ...KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter
ST. LOUIS and BUDAPEST, Hungary, June 18 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to certain of KV's technologie...Gaiam and Discovery Communications Announce Exclusive Licensing Deal
NEW YORK, June 16 /PRNewswire-FirstCall/ -- Gaiam, Inc., the leading distributor of lifestyle media and fitness accessories, today announced that it has signed an exclusive home video license agreement with Discovery Communications. Under the three-year agreement, Gaiam will release programming fr...Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement
SAN MARCOS, Calif., March 9 /PRNewswire-FirstCall/ --Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII ), a leading formulator and manufacturer of customized nutritional supplements, and Compound Solutions, Inc. ("CSI"), a science and marketing based distributor of raw materials to ...Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development
ALISO VIEJO, Calif., March 3 /PRNewswire/ -- Bausch & Lomb, the global eye health company, has entered into a licensing agreement with Santen Pharmaceutical Co., Ltd., for the development of certain intraocular lens (IOL) materials. Under the terms of the agreement, Bausch & Lomb has...Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
BELLEVILLE, Ontario and CHADDS FORD, Pa., July 10 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP ) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with ...Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
Technology to improve accuracy of ovarian cancer diagnosis TAMPA, Fla., May 14 /PRNewswire/ -- Moffitt Cancer Center and Frantz BioMarkers, LLC have signed a license agreement on phospholipid biomarkers of ovarian cancer. Frantz BioMarkers, which has been granted exclusive worldwide ...Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
DURHAM, N.C., May 13 /PRNewswire/ -- Addrenex Pharmaceuticals today expanded its pipeline of products aimed at adrenergic regulation with the signing of an agreement to license a new drug for the treatment of narcolepsy, a chronic and debilitating sleep disorder, as well as other neurologic and ps...Ironwood Announces Linaclotide European Licensing Agreement with Almirall
- Ironwood Will Receive Up To $55 Million in Near Term Payments - CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that the company has entered into an out-licensing agreement with Laboratorios Almirall, S.A. for European rights to develop and commerciali...CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
Partner to Make Direct Investment in CEL-SCI VIENNA, Va., Nov. 3 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE: CVM ) announced today that it has expanded its exclusive licensing agreement for Multikine(R) with Orient Europharma Co., Ltd. ("Orient Europharma"), a leading pharmaceutica...Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
Companies to Study B-Raf Kinase Inhibitors for Cancer Treatments INDIANAPOLIS, Ind. and LAWRENCE, Kan., Oct. 3 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and privately-held Deciphera Pharmaceuticals, LLC today announced that the two companies have entered into a collabor...Genzyme and Isis Complete Licensing of Mipomersen
Conference call to be held today at 10 a.m. EDT CAMBRIDGE, Mass., and CARLSBAD, Calif., June 24 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced the finalization of the license and collaboration agreement for mip...Lilly and TransPharma Medical Announce Licensing and Development Agreement
Lilly Gains Access to Transdermal PTH Program for Osteoporosis INDIANAPOLIS, Ind. and LOD, Israel, June 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and TransPharma Medical Ltd. today announced that the two companies have entered into a licensing and development agreem...Dolce & Gabbana Ophthalmic Collection
Description:... and professionalism. Glamour and style. Creativity and cutting-edge design. Dolce & Gabbana and Luxottica, two market-leading companies, signed a new licensing agreement in October 2005.The Dolce & Gabbana brand was formed in 1985 by the famous designer duo, Domenico Dolce and Stefano Gabbana, who blended sen...Full Service Clinical Reference Laboratory
Description:...AP) accreditation. This award indicates that Enzo has passed an extremely rigorous series of inspections far more sophisticated than those mandated by licensing authorities....Just the Facts in Emergency Medicine
Description:... The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC
JERICHO, N.Y., July 30 /PRNewswire-FirstCall/ -- bioMETRX Inc., (OTC Bulletin Board: BMRX), today announced that it has completed an exclusive 15 year licensing agreement with EZ Print, LLC for the advanced remote printing technology acquired through the company's Sequiam asset purchase agreem...U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
The University of Massachusetts Medical School and the Carnegie Institution of Washington announced today that they have entered into licensing agreements with Oxford BioMedica (LSE: OXB), a gene therapy company, that grants the company rights to key RNA interference (RNAi) patent rights. Th...New licensing agreement to maximize AIDS drug development
Longtime collaborators CONRAD and the Biosyn Division of Cellegy Pharmaceuticals, Inc. today announced a non-exclusive licensing agreement to research and develop Biosyn-patented microbicides for the prevention of HIV and other sexually transmitted diseases. The three microbicides covered unde...Aware, Inc. Reports Second Quarter 2009 Financial Results
...overnment regulations. DSL factors include, but are not limited to: our DSL licensing and DSL test and diagnostic businesses depend upon a limited number of cust...y continue to be a cyclical demand for DSL chipsets; the success of our DSL licensing and test and diagnostics products businesses requires telephone companies t...Indonesia Now Using MegaMatcher Biometric Technology in Integrated Passport Issuance System
...ents of MegaMatcher can be used on both Microsoft Windows and Linux operating systems. MegaMatcher 3.0 SDK is available with highly competitive licensing options through Neurotechnology or from distributors worldwide. A 30-day trial version with full functionality is also available for download. For mo...Versartis presents positive preclinical data on 2 product candidates at ENDO 09
... (IL-1ra-rPEG) for treatment of type 1 and type 2 diabetes, at the Endocrine Society's Annual Meeting in Washington, DC. Versartis, through a unique licensing agreement with Amunix, Inc., uses the Amunix proprietary recombinant PEGylation (rPEG) technology to extend the half-life of established biologics. T...Partnership to accelerate Trudeau Institute discoveries to patient care
...o HRI professional staff and resources both in technology transfer and sponsored research management. HRI brings a well-developed network of corporate licensing and business contacts, funding sources, investors, and researchers. Each of Trudeau's existing and future inventions will be subject to a methodical a...UGA licenses new Bermuda grass that thrives in sun and shade
... Turf, a Georgia-based company specializing in marketing new turfgrasses, has contracted The Turfgrass Group of Ft. Valley, Ga., to exclusively handle licensing of TifGrand for sod production. TifGrand will be licensed to a selected number of growers beginning in summer 2009; it is expected to be available in ...Aware, Inc. Reports First Quarter 2009 Financial Results
...overnment regulations. DSL factors include, but are not limited to: our DSL licensing and DSL test and diagnostic businesses depend upon a limited number of cust...y continue to be a cyclical demand for DSL chipsets; the success of our DSL licensing and test and diagnostics products businesses requires telephone companies t...Association for Molecular Pathology joins ACLU to challenge gene patents
... In 2008, AMP adopted a revised Policy Statement on gene patenting and the licensing of intellectual property that urged an end to the practice of granting pate...to greatly limit those who can access the gene through the use of exclusive licensing agreement. As a result, scientific research has been delayed, limited or ev...Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Chugai Pharmaceutical Gains Rights to Develop and Market Nitazoxanide for the Treatment of Chronic Hepatitis C TAMPA, Fla., Feb. 17 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, today announced...Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
DUBLIN, Ireland, January 9 /PRNewswire/ -- Azur Pharma Limited ("Azur Pharma") today announced that it licensed the exclusive U.S. marketing rights for Niravam(R) (alprazolam orally disintegrating tablets), Parcopa(R) (carbidopa-levodopa orally disintegrating tablets), Kemstro(TM) (baclofen or...Codexis, Teva in Licensing Agreement Final
REDWOOD CITY, Calif., Jan. 7 /PRNewswire/ -- Codexis, Inc. today announced a licensing agreement with Teva Pharmaceutical Industries Ltd., to produce an important publicly-undisclosed generic product, using a proprietary Codexis biocatalyst. Teva, the largest generic drug manufacturer in the ...ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology
UNION CITY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis instruments for both the medical and veterinary markets, announced today that it has entered into a license agreement for co-exclusive worldwid...DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
PARSIPPANY, N.J. and LEIDEN, Netherlands, Nov. 25 /PRNewswire/ -- DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX), today announced that Hungary-based Gedeon Richter Plc. signed a commercial...